Kamlesh Khunti to Aged
This is a "connection" page, showing publications Kamlesh Khunti has written about Aged.
Connection Strength
0.580
-
Obesity, chronic disease, age, and in-hospital mortality in patients with covid-19: analysis of ISARIC clinical characterisation protocol UK cohort. BMC Infect Dis. 2021 Jul 31; 21(1):717.
Score: 0.017
-
Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England. Eur J Epidemiol. 2021 Jun; 36(6):605-617.
Score: 0.017
-
Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis of the ISARIC CCP-UK Cohort. Obesity (Silver Spring). 2021 07; 29(7):1223-1230.
Score: 0.017
-
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol. 2021 05; 9(5):293-303.
Score: 0.017
-
Ethnicity, household composition and COVID-19 mortality: a national linked data study. J R Soc Med. 2021 04; 114(4):182-211.
Score: 0.017
-
"It's so tough for us now" - COVID-19 has negatively impacted religious practices relating to death among minority ethnic groups. Public Health. 2021 May; 194:146-148.
Score: 0.017
-
Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank. Int J Obes (Lond). 2021 05; 45(5):1155-1159.
Score: 0.017
-
Multimorbidity and SARS-CoV-2 infection in UK Biobank. Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):775-776.
Score: 0.016
-
Obesity and risk of COVID-19: analysis of UK biobank. Prim Care Diabetes. 2020 10; 14(5):566-567.
Score: 0.016
-
Therapeutic uncertainties in people with cardiometabolic diseases and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19). Diabetes Obes Metab. 2020 10; 22(10):1942-1945.
Score: 0.016
-
Movement through Active Personalised engagement (MAP) - a self-management programme designed to promote physical activity in people with multimorbidity: study protocol for a randomised controlled trial. Trials. 2018 Oct 20; 19(1):576.
Score: 0.014
-
Cardiovascular, cancer and mortality events after bariatric surgery in people with and without pre-existing diabetes: A nationwide study. J Diabetes. 2019 Apr; 11(4):265-272.
Score: 0.014
-
Risk of hypoglycaemia in people aged =65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus. Int J Clin Pract. 2018 Oct; 72(10):e13240.
Score: 0.014
-
Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes Obes Metab. 2018 09; 20(9):2169-2178.
Score: 0.014
-
Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates. Diabetologia. 2018 07; 61(7):1592-1602.
Score: 0.014
-
The association between depressive symptoms and insulin resistance, inflammation and adiposity in men and women. PLoS One. 2017; 12(11):e0187448.
Score: 0.013
-
Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: a UK Biobank observational study. Eur Heart J. 2017 Nov 14; 38(43):3232-3240.
Score: 0.013
-
Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open. 2017 Oct 16; 7(10):e016358.
Score: 0.013
-
Therapeutic inertia amongst general practitioners with interest in diabetes. Prim Care Diabetes. 2018 02; 12(1):87-91.
Score: 0.013
-
The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2017 11; 34(11):1508-1520.
Score: 0.013
-
Self-knowledge of HbA1c in people with Type 2 Diabetes Mellitus and its association with glycaemic control. Prim Care Diabetes. 2017 10; 11(5):414-420.
Score: 0.013
-
Older people with Type 2 diabetes, including those with chronic kidney disease or dementia, are commonly overtreated with sulfonylurea or insulin therapies. Diabet Med. 2017 09; 34(9):1219-1227.
Score: 0.013
-
Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies. Eur Heart J. 2017 May 21; 38(20):1608-1612.
Score: 0.013
-
Risk factors and outcome differences in hypoglycaemia-related hospital admissions: A case-control study in England. Diabetes Obes Metab. 2017 10; 19(10):1371-1378.
Score: 0.013
-
Associations of moderate-to-vigorous-intensity physical activity and body mass index with glycated haemoglobin within the general population: a cross-sectional analysis of the 2008 Health Survey for England. BMJ Open. 2017 04 03; 7(4):e014456.
Score: 0.013
-
Comparison of body mass index at diagnosis of diabetes in a multi-ethnic population: A case-control study with matched non-diabetic controls. Diabetes Obes Metab. 2017 07; 19(7):1014-1023.
Score: 0.013
-
Predicting hospital stay, mortality and readmission in people admitted for hypoglycaemia: prognostic models derivation and validation. Diabetologia. 2017 06; 60(6):1007-1015.
Score: 0.013
-
Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care. 2015 Feb; 38(2):316-22.
Score: 0.011
-
Association of cardiac and non-cardiac chronic disease comorbidity on glycaemic control in a multi-ethnic population with type 1 and type 2 diabetes. Postgrad Med J. 2011 Nov; 87(1033):763-8.
Score: 0.009
-
Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail. 2002 Dec; 4(6):771-7.
Score: 0.005
-
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021 08 26; 374:n1931.
Score: 0.004
-
Sociodemographic inequality in COVID-19 vaccination coverage among elderly adults in England: a national linked data study. BMJ Open. 2021 07 23; 11(7):e053402.
Score: 0.004
-
Risk factors for severe outcomes in people with diabetes hospitalised for COVID-19: a cross-sectional database study. BMJ Open. 2021 07 22; 11(7):e051237.
Score: 0.004
-
Cohort profile: National Diabetes Audit for England and Wales. Diabet Med. 2021 09; 38(9):e14616.
Score: 0.004
-
Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries. BMJ. 2021 05 19; 373:n1137.
Score: 0.004
-
A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection. Diabetologia. 2021 08; 64(8):1717-1724.
Score: 0.004
-
Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes. J Clin Endocrinol Metab. 2021 04 23; 106(5):1255-1268.
Score: 0.004
-
Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021 03 31; 372:n693.
Score: 0.004
-
The impact of COVID-19 restrictions on accelerometer-assessed physical activity and sleep in individuals with type 2 diabetes. Diabet Med. 2021 10; 38(10):e14549.
Score: 0.004
-
Association of Timing and Balance of Physical Activity and Rest/Sleep With Risk of COVID-19: A UK Biobank Study. Mayo Clin Proc. 2021 01; 96(1):156-164.
Score: 0.004
-
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020 10; 8(10):823-833.
Score: 0.004
-
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020 10; 8(10):813-822.
Score: 0.004
-
Body mass index and the risk of COVID-19 across ethnic groups: Analysis of UK Biobank. Diabetes Obes Metab. 2020 10; 22(10):1953-1954.
Score: 0.004
-
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme. Diabetes Obes Metab. 2019 11; 21(11):2474-2485.
Score: 0.004
-
20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study. Lancet Public Health. 2019 08; 4(8):e406-e420.
Score: 0.004
-
Self-Compassion, Metabolic Control and Health Status in Individuals with Type 2 Diabetes: A UK Observational Study. Exp Clin Endocrinol Diabetes. 2021 Jun; 129(6):413-419.
Score: 0.004
-
Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study. Diabetes Res Clin Pract. 2019 May; 151:20-32.
Score: 0.004
-
Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting. Diabetes Obes Metab. 2019 06; 21(6):1373-1380.
Score: 0.004
-
Factors influencing safe glucose-lowering in older adults with type 2 diabetes: A PeRsOn-centred ApproaCh To IndiVidualisEd (PROACTIVE) Glycemic Goals for older people: A position statement of Primary Care Diabetes Europe. Prim Care Diabetes. 2019 08; 13(4):330-352.
Score: 0.004
-
Update on the General Practice Optimising Structured Monitoring to Improve Clinical Outcomes in Type 2 Diabetes (GP-OSMOTIC) trial: statistical analysis plan for a multi-centre randomised controlled trial. Trials. 2019 Jan 30; 20(1):93.
Score: 0.004
-
Differences in objectively measured physical activity and sedentary behaviour between white Europeans and south Asians recruited from primary care: cross-sectional analysis of the PROPELS trial. BMC Public Health. 2019 Jan 21; 19(1):95.
Score: 0.004
-
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol. 2018 11 28; 17(1):150.
Score: 0.004
-
Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment. Hypertension. 2018 11; 72(5):1117-1124.
Score: 0.004
-
Associations of Physical Behaviours and Behavioural Reallocations with Markers of Metabolic Health: A Compositional Data Analysis. Int J Environ Res Public Health. 2018 10 17; 15(10).
Score: 0.004
-
Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes. Diabetes Care. 2018 10; 41(10):2096-2104.
Score: 0.003
-
GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice. BMJ Open. 2018 07 17; 8(7):e021435.
Score: 0.003
-
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL. J Am Coll Cardiol. 2018 06 05; 71(22):2497-2506.
Score: 0.003
-
Beyond Cut Points: Accelerometer Metrics that Capture the Physical Activity Profile. Med Sci Sports Exerc. 2018 06; 50(6):1323-1332.
Score: 0.003
-
Weight loss and mortality risk in patients with different adiposity at diagnosis of type 2 diabetes: a longitudinal cohort study. Nutr Diabetes. 2018 06 01; 8(1):37.
Score: 0.003
-
Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: a matched case-control analysis. Cardiovasc Diabetol. 2018 05 15; 17(1):70.
Score: 0.003
-
Interventions for improving modifiable risk factor control in the secondary prevention of stroke. Cochrane Database Syst Rev. 2018 05 07; 5:CD009103.
Score: 0.003
-
The impact of neighbourhood walkability on the effectiveness of a structured education programme to increase objectively measured walking. J Public Health (Oxf). 2018 03 01; 40(1):82-89.
Score: 0.003
-
SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-analysis. Prim Care Diabetes. 2018 06; 12(3):265-283.
Score: 0.003
-
Associations of Physical Activity Intensities with Markers of Insulin Sensitivity. Med Sci Sports Exerc. 2017 Dec; 49(12):2451-2458.
Score: 0.003
-
Reallocating sitting time to standing or stepping through isotemporal analysis: associations with markers of chronic low-grade inflammation. J Sports Sci. 2018 Jul; 36(14):1586-1593.
Score: 0.003
-
Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification. JACC Heart Fail. 2018 01; 6(1):18-26.
Score: 0.003
-
Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project. Eur J Prev Cardiol. 2017 10; 24(15):1637-1645.
Score: 0.003
-
External national validation of the Leicester Self-Assessment score for Type 2 diabetes using data from the English Longitudinal Study of Ageing. Diabet Med. 2017 11; 34(11):1575-1583.
Score: 0.003
-
Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry®. J Am Heart Assoc. 2017 Aug 11; 6(8).
Score: 0.003
-
Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment. Diabetes Obes Metab. 2018 01; 20(1):103-112.
Score: 0.003
-
Breaking up sedentary time with seated upper body activity can regulate metabolic health in obese high-risk adults: A randomized crossover trial. Diabetes Obes Metab. 2017 12; 19(12):1732-1739.
Score: 0.003
-
What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries. BMJ Open. 2017 Jul 11; 7(7):e016180.
Score: 0.003
-
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors). Circulation. 2017 Jul 18; 136(3):249-259.
Score: 0.003
-
Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study. BMJ Open. 2017 05 10; 7(5):e013851.
Score: 0.003
-
The association between air pollution and type 2 diabetes in a large cross-sectional study in Leicester: The CHAMPIONS Study. Environ Int. 2017 07; 104:41-47.
Score: 0.003
-
Associations of reallocating sitting time into standing or stepping with glucose, insulin and insulin sensitivity: a cross-sectional analysis of adults at risk of type 2 diabetes. BMJ Open. 2017 01 13; 7(1):e014267.
Score: 0.003